Name: 글로벌 시장 동향
SKU: MD8510
Availability: InStock

보고서 요약(국문)

개요
전 세계 자동 혈액 분석기 시장은 2023년 4억 5,600만 달러 규모에 도달했으며, 2024년부터 2031년까지 연평균 7.2%의 성장률을 보이며 2031년에는 7억 9,500만 달러에 이를 것으로 예상됩니다.
자동 혈액 분석기는 혈액 샘플에서 다양한 종류의 적혈구, 백혈구, 혈소판, 헤모글로빈 및 헤마토크리트 수치를 측정하는 컴퓨터화된 고도로 전문화된 장비입니다.
또한, 기준 범위를 벗어난 결과를 알려주는 프로그래밍 가능한 자동 경보 시스템을 갖추고 있습니다. 혈액 분석기는 질병의 진단 및 모니터링, 예후 예측, 그리고 후속 검진에 사용되며, 혈우병, 혈액암, 혈전 등 다양한 혈액 관련 질환에 광범위하게 사용됩니다. 그 외에도 백혈병, 빈혈, 수혈, 악성 림프종 등 혈액학적 진단이 필요한 질환에도 사용됩니다.

혈액 질환 유병률 증가, 기술 발전, 자동 혈액학 기기 도입률 상승 등의 요인이 시장을 주도하고 있습니다.
시장 동향: 성장 동인
혈액 질환 유병률 증가
전 세계 자동 혈액 분석기 시장의 수요는 여러 요인에 의해 주도되고 있습니다. 주요 요인 중 하나는 혈액 질환 발생률의 증가입니다. 호주 정부 보건복지부는 2022년 12월, 매년 약 33만 명의 혈액 질환 신생아가 태어나고 있으며, 이 중 83%가 겸상 적혈구 질환, 17%가 지중해성 빈혈을 앓고 있다고 보고했습니다. 또한 임산부의 7%가 헤모글로빈 장애를 가지고 있으며, 전 세계적으로 1% 이상의 부부가 혈액 질환 위험에 처해 있다고 밝혔습니다.

2023년 10월에 발표된 세계혈우병연맹의 연구에 따르면, 전 세계적으로 혈우병을 앓고 있는 남성은 830,895명에 달하며, 이 중 약 282,266명은 중증 혈우병을 앓고 있는데, 이는 진단이 제대로 이루어지지 않는 가장 흔한 유형입니다. 조기 진단과 치료는 혈액 세포 질환을 가진 환자의 삶의 질을 유지하는 데 가장 효과적인 방법 중 하나입니다.
또한, 업계 주요 업체들이 혈액 분석기의 기술적 이점에 더욱 집중함에 따라 이러한 시장 성장이 촉진될 것으로 예상됩니다. 예를 들어, 2022년 7월 Sysmex Corporation은 혈액학 분야의 주력 모델인 XR 시리즈 자동 혈액 분석기에 연결할 수 있는 새로운 검체 이송 시스템 모듈을 출시했습니다.

또한, 2022년 3월 Mindray는 전혈구 검사(CBC)와 적혈구 침강 속도(ESR) 검사를 모두 포함하는 혁신적인 혈액 분석기 시리즈인 BC-700 시리즈를 출시했습니다. 개방형 바이알 모델인 BC-700/BC-720과 자동 로더 모델인 BC-760/BC-780으로 구성된 이 시리즈는 고급 제품에 적용되는 첨단 진단 기술을 중규모 실험실에 제공하도록 설계되었습니다.
제약 요인
분석기의 높은 가격, 시간 소모적이고 엄격한 규제 요건, 숙련된 기술자의 부족, 제한적인 보험 적용 정책 등의 요인이 시장 성장을 저해할 것으로 예상됩니다.
세분화 분석
글로벌 자동 혈액 분석기 시장은 제품 및 서비스, 유형, 응용 분야, 최종 사용자를 기준으로 세분화됩니다.

3부분 혈액 분석기 부문은 전 세계 자동 혈액 분석기 시장 점유율의 약 65.4%를 차지했습니다.
3부분 혈액 분석기 부문은 예측 기간 동안 가장 큰 시장 점유율을 유지할 것으로 예상됩니다. 3부분 혈액 분석기는 백혈구의 양을 전기적으로 측정하고 혈액 세포를 크기에 따라 소형 백혈구 그룹(림프구), 중형 백혈구 그룹(단핵구, 호산구, 호염기구), 대형 백혈구 그룹의 세 그룹으로 분류합니다. 이 검사는 빈혈, 감염, 백혈병 등 다양한 질환을 진단하는 데 사용할 수 있습니다.
또한, 시장의 주요 업체들이 신제품을 출시하고 혈액 분석기에 혁신적인 기술을 도입함에 따라 이 부문의 성장이 촉진될 것입니다. 예를 들어, 아가페(Agappe)는 2024년 3월에 최첨단 혈액 분석기를 출시할 예정입니다. AG Innovate는 고객 참여 프로그램으로, 혁신적인 3세대 자동 혈액 분석기와 AE 기반 CLIA 분석기의 공개를 고객들이 직접 경험할 수 있는 자리입니다.
마찬가지로, Dymind는 2024년 2월 Medlab Middle East에서 DH20 3파트 자동 혈액 분석기를 선보일 예정입니다. 컴팩트하고 사용하기 쉬운 DH20은 단 9μl의 검체량으로 더 많은 임상 매개변수를 측정할 수 있으며, RF 카드 및 바코드 기능을 옵션으로 제공합니다.
또한, Sysmex Europe은 2022년 4월, 중요한 대용량 시장 부문의 요구에 부응하는 새로운 3파트 분획 시스템인 'XQ-320 XQ 시리즈 자동 혈액 분석기'를 출시했습니다. XQ-320은 신뢰할 수 있는 기술과 새로운 차원의 사용 편의성을 통해 다양한 임상 실험실 환경에 탁월한 품질을 제공합니다.

지리적 분석
북미는 전 세계 자동 혈액 분석기 시장 점유율의 약 43.2%를 차지했습니다.
북미 지역은 혈액 질환 부담 증가와 주요 업체들의 혈액 분석기 도입 확대로 인해 예측 기간 동안 가장 큰 시장 점유율을 유지할 것으로 예상되며, 이는 시장 성장을 견인하는 요인입니다.
혈액암은 이 지역 시장 성장의 주요 동인 중 하나입니다. 백혈병 및 림프종 협회(Leukemia and Lymphoma Society)에 따르면, 2023년 미국에서는 약 3분마다 한 명씩 백혈병, 림프종 또는 다발성 골수종 진단을 받았습니다. 미국에서 백혈병, 림프종 또는 다발성 골수종 진단을 받는 사람은 총 184,720명으로 추산됩니다.
또한, 업계 주요 업체들의 신제품 출시 및 승인도 시장 성장을 촉진하는 요인입니다. 예를 들어, 2023년 8월 애보트는 첨단 알리니티 h-시리즈 혈액학 시스템에 대해 미국 식품의약국(FDA) 승인을 획득하여, 전국의 실험실에서 애보트의 알리니티 진단 제품군을 통해 전혈구 검사(CBC)를 수행할 수 있도록 했습니다.
또한, 2024년 1월 호리바 메디컬은 CE-IVDR 인증을 획득하고 미국 FDA 승인을 기다리고 있는 새로운 고처리량 자동 혈액학 플랫폼 HELO 2.0을 출시했습니다. 호리바 메디컬의 이전 HELO의 성공에 힘입어, 이 차세대 고급 혈액학 제품군은 고객과의 협의를 통해 설계되어 고처리량 완전 자동 혈액학의 모든 요구 사항을 충족하고 성능을 더욱 향상시켰습니다.

시장 세분화
제품 및 서비스별
• 기기
o 3파트 혈액 분석기
o 5파트 혈액 분석기
o 현장 진단용 혈액 분석기
o 기타
• 시약 및 소모품
• 서비스
유형별
• 완전 자동 혈액 분석기
• 반자동 혈액 분석기
적용 분야별
• 출혈성 질환
• 혈액암
• 빈혈
• 감염
• 면역 질환
• 기타
최종 사용자별
• 병원
• 임상 검사실
• 학술 및 연구 기관
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 스페인
o 이탈리아
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 한국
o 아시아 태평양 지역(기타)
• 중동 및 아프리카
경쟁 환경
자동 혈액 분석기 시장의 주요 글로벌 업체로는 Beckman Coulter, Inc., Accurex, Everlife CPC Diagnostics, Sysmex, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Abbott, Horiba Medical, Biobase Biodusty(Shandong) Co., Ltd, Siemens Healthineers 및 F. Hoffmann-La Roche Ltd 등이 있습니다.
주요 개발 사항
 2024년 6월, Horiba는 적혈구 침강 속도(ESR) 검사를 통합한 새로운 모델을 출시하여 소형 혈액 분석 기기 제품군을 확장했습니다. 이 모델은 신속한 결과 제공과 포괄적인 질병 프로파일링을 통해 진단 기능을 향상시켰습니다.

 2024년 2월, 중국 선전에 위치한 Dymind Biotechnology는 Medlab Middle East 2024에서 혈액학, 응고, POCT, 면역학 및 수의학 분야의 혁신적인 의료 솔루션을 선보일 예정이며, 여기에는 혁신적인 기능을 갖춘 새로운 고급 혈액 분석기 DH-800도 포함됩니다.
 2023년 5월, Siemens Healthineers는 차세대 혈액 분석기인 Atellica HEMA 570 및 Atellica HEMA 580을 출시하여 환자들이 더 빠르게 결과를 얻을 수 있도록 워크플로우 장벽을 제거했습니다. 환자 치료에 필수적인 전혈구 검사(CBC)는 실험실에서 가장 많이 수행되는 진단 검사 중 하나이며, 종종 환자의 질병에 대한 첫 번째 징후를 제공합니다.
이 보고서를 구매해야 하는 이유:

• 제품 및 서비스, 응용 분야, 최종 사용자 및 지역별 글로벌 자동 혈액 분석기 시장 세분화를 시각화하고 주요 상업 자산 및 업체를 파악하기 위함입니다.

• 트렌드 분석 및 공동 개발을 통해 상업적 기회를 파악합니다.

• 모든 세그먼트를 포함한 자동 혈액 분석기 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 자료를 Excel 파일로 제공합니다.

글로벌 자동 혈액 분석기 보고서는 약 70개의 표, 69개의 그림, 182페이지 분량입니다.
주요 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
The global automated hematology analyzer market reached US$ 456 million in 2023 and is expected to reach US$ 795 million by 2031, growing with a CAGR of 7.2% during the forecast period 2024-2031.
Automated hematology analyzers are computerized, highly specialized machines that count the number of different types of red and white blood cells, blood platelets, hemoglobin, and hematocrit levels in a blood sample.
They include programmable automated alarm systems for indicating results outside the reference range. Hematology analyzers are concerned with the detection, and monitoring of diseases, prognosis, and subsequent screening and are extensively used against various blood-related diseases such as hemophilia, blood cancer, and blood clots. Other diseases include leukemia, anemia, blood transfusion, malignant lymphomas, and others where hematology diagnosis is used.
The market is driven by factors such as the rise in the prevalence of blood disorders, increasing technological advancements, and rising adoption rates of automated hematology instruments.
Market Dynamics: Drivers
Rise in Prevalence of Blood Disorders
The demand for the global automated hematology analyzer market is driven by multiple factors. One of the primary factors is the increase in the incidence of blood disorders driving the market growth. The Department of Health and Aged Care of the Australian Government reported in December 2022 that there were about 330,000 affected babies born every year, 83% of whom had disorders of sickle cell, 17% had thalassemia, 7% of expectant mothers had hemoglobin disorders, and more than 1% of the couples worldwide were at risk.
According to a World Federation of Hemophilia research study published in October 2023, there were a higher number of 830,895 males worldwide having hemophilia, and about 2,82,266 of these have a severe type of condition that is the most underdiagnosed. Early diagnosis, as well as treatment, are some of the most effective ways to maintain a patient's quality of life when they have a blood cell problem.
Moreover, key players in the industry more focus on the technological advantages of the hematology analyzer would drive this market growth. For instance, in July 2022, Sysmex Corporation announced the launch of new sample transportation system modules that can be connected to the XR-Series Automated Hematology Analyzer (XR-Series), its flagship model in the hematology field.
Also, in March 2022, Mindray launched the new BC-700 Series, a revolutionary hematology analyzer series that incorporates both complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests. This series, including two open vial models BC-700/BC-720 and two autoloader models BC-760/BC-780, is designed to empower medium-volume laboratories with advanced diagnostics technologies that are applied in the premium products.
Restraints
Factors such as the high cost of the analyzer, time-consuming & stringent regulatory requirements, limited availability of skilled technicians, and limited reimbursement policies are expected to hamper the market.
Segment Analysis
The global automated hematology analyzer market is segmented based on product & service, type, application, and end-user.
The 3-part hematology analyzer segment accounted for approximately 65.4% of the global automated hematology analyzer market share
The 3-part hematology analyzer segment is expected to hold the largest market share over the forecast period. The 3-part hematology analyzer measures the volume of white blood cells electrically & categorizes blood cells, based on their size, divides into three groups: a small white blood cell group (lymphocytes), a medium-sized white blood cell group (monocytes, eosinophils, and basophils), & large white blood cell group. This test can be used to detect a variety of conditions, such as anemia, infection, and leukemia.
Moreover, key players in the market product launches and introducing innovative technological advancements in the hematology analyzers would drive this segment's growth. For instance, in March 2024, Agappe will launch the most advanced hematology analyzers. AG Innovate will be a customer engagement program where the customers can experience the unveiling of a revolutionary automated 3rd generation hematology analyzer and AE-powered CLIA analyzer.
Similarly, at Medlab Middle East in February 2024, Dymind is also showcasing the DH20 3-part auto hematology analyzer. Compact and user-friendly, the DH20 can measure more clinical parameters using only 9ul sample volume and comes with an optional RF card and barcode function.
Also, in April 2022, Sysmex Europe has recently launched its new three-part differential system ‘XQ-320 XQ-Series Automated Hematology Analyzer’, answering the needs of this important high-volume market segment. XQ-320 brings excellence in quality to a diverse range of clinical laboratory environments with reliable technology and a new level of usability.
Geographical Analysis
North America accounted for approximately 43.2% of the global automated hematology analyzer market share
North American region is expected to hold the largest market share over the forecast period owing to the increasing burden of blood disorders and the growth in the adoption of hematology analyzers by the major players in this region helps to drive this market growth.
Blood Cancers are one of the driving factors in this region. According to the Leukemia and Lymphoma Society, in 2023, approximately every 3 minutes, one person in the U.S. is diagnosed with leukemia, lymphoma, or myeloma. An estimated combined total of 184,720 people in the U.S. are expected to be diagnosed with leukemia, lymphoma, or myeloma.
Moreover, key players in the industry introducing new product launches and approvals help to drive this market growth. For instance, in August 2023, Abbott received U.S. Food and Drug Administration clearance for its advanced Alinity h-series hematology system, paving the way for laboratories throughout the country to run complete blood counts (CBC) as a part of Abbott’s Alinity family of diagnostic products.
Also, in January 2024, HORIBA Medical launched the new HELO 2.0 high throughput automated hematology platform which is CE-IVDR approved, with pending US FDA approval. Following the success of HORIBA Medical’s previous HELO, this new generation high-end hematology range has been designed in consultation with customers to further improve and cover all needs of high throughput fully automated hematology.
Market Segmentation
By Product & Service
• Instruments
o 3 Part Hematology Analyzer
o 5 Part Hematology Analyzer
o Point-of-care Testing Hematology Analyzers
o Others
• Reagents & Consumables
• Services
By Type
• Fully-Automated Hematology Analyzers
• Semi-automated Hematology Analyzers
By Application
• Hemorrhagic Conditions
• Blood Cancer
• Anaemia
• Infections
• Immune Disorders
• Others
By End-user
• Hospitals
• Clinical Laboratories
• Academic and Research Institutes
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the automated hematology analyzer market include Beckman Coulter, Inc., Accurex, Everlife CPC Diagnostics, Sysmex, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Abbott, Horiba Medical, Biobase Biodusty(Shandong), Co., Ltd, Siemens Healthineers and F. Hoffmann-La Roche Ltd among others.
Key Developments
 In June 2024, Horiba expanded its line of compact hematology instruments by introducing new models that integrate Erythrocyte Sedimentation Rate (ESR) testing, enhancing diagnostic capabilities with rapid results and comprehensive disease profiling.
 In February 2024, Dymind Biotechnology (Shenzhen, China) is introducing its breakthroughs in medical solutions for hematology, coagulation, POCT, immunology, and veterinary at Medlab Middle East 2024, including its new high-end hematology analyzer DH-800 with innovative functions.
 In May 2023, Siemens Healthineers launched next-gen hematology analyzers, workflow barriers removed to help patients get results faster. The Atellica HEMA 570 Analyzer and the Atellica HEMA 580 Analyzer. Vital to patient care, the complete blood count (CBC) is among the most performed diagnostic tests in the lab and often provides the first indication of illness in a patient.
Why Purchase the Report?
• To visualize the global automated hematology analyzer market segmentation based on product & service, application, end-user, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of automated hematology analyzer market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available in Excel consisting of key products of all the major players.
The global automated hematology analyzer report would provide approximately 70 tables, 69 figures, and 182 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product & Service
3.2. Snippet by Type
3.3. Snippet by Application
3.4. Snippet by End-user
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rise in Prevalence of Blood Disorders
4.1.1.2. Increasing Technological Advancements and Rising Adoption Rates of Automated Hematology Instruments
4.1.2. Restraints
4.1.2.1. High Cost of the Analyzer
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. By Product & Service
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Service
6.1.2. Market Attractiveness Index, By Product & Service
6.2. Instruments
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. 3-Part Hematology Analyzer
6.4. 5 Part Hematology Analyzer
6.5. Point-of-care Testing Hematology Analyzers
6.6. Others
6.7. Reagents & Consumables
6.8. Services
7. By Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Fully Automated Hematology Analyzers
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Semi-Automated Hematology Analyzers
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Hemorrhagic Conditions
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Blood Cancer
8.4. Anaemia
8.5. Infections
8.6. Immune Disorders
8.7. Others
9. By End-user
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
9.1.2. Market Attractiveness Index, By End-user
9.2. Hospitals
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Clinical Laboratories
9.4. Academic and Research Institutes
9.5. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Service
10.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.3.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.3.1. U.S.
10.3.3.2. Canada
10.3.3.3. Mexico
10.4. Europe
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Service
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. Germany
10.4.7.2. U.K.
10.4.7.3. France
10.4.7.4. Spain
10.4.7.5. Italy
10.4.7.6. Rest of Europe
10.5. South America
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Service
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. Brazil
10.5.7.2. Argentina
10.5.7.3. Rest of South America
10.6. Asia-Pacific
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Service
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.6.7.1. China
10.6.7.2. India
10.6.7.3. Japan
10.6.7.4. South Korea
10.6.7.5. Rest of Asia-Pacific
10.7. Middle East and Africa
10.7.1. Introduction
10.7.2. Key Region-Specific Dynamics
10.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product & Service
10.8.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.8.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.8.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Beckman Coulter, Inc
12.1.1. Company Overview
12.1.2. ProductPortfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Accurex
12.3. Everlife CPC Diagnostics
12.4. Sysmex
12.5. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
12.6. Abbott
12.7. Horiba Medical
12.8. Biobase Biodusty(Shandong), Co., Ltd
12.9. Siemens Healthineers
12.10. F. Hoffmann-La Roche Ltd
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

Beckman Coulter, Inc, 4.	Key Developments, Accurex, Everlife CPC Diagnostics, Sysmex, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Abbott, Horiba Medical, Biobase Biodusty(Shandong), Co., Ltd, Siemens Healthineers, F. Hoffmann-La Roche Ltd

표 목록 (Tables)

List of Tables Table 1 Global Automated Hematology Analyzer Market Value, By Product Type, 2025, 2029 & 2033 (US$ Million)

Table 2 Global Automated Hematology Analyzer Market Value, By Application, 2025, 2029 & 2033 (US$ Million)

Table 3 Global Automated Hematology Analyzer Market Value, By End-User, 2025, 2029 & 2033 (US$ Million)

Table 4 Global Automated Hematology Analyzer Market Value, By Region, 2025, 2029 & 2033 (US$ Million)

Table 5 Global Automated Hematology Analyzer Market Value, By Product Type, 2025, 2029 & 2033 (US$ Million)

Table 6 Global Automated Hematology Analyzer Market Value, By Product Type, 2022-2033 (US$ Million)

Table 7 Global Automated Hematology Analyzer Market Value, By Application, 2025, 2029 & 2033 (US$ Million)

Table 8 Global Automated Hematology Analyzer Market Value, By Application, 2022-2033 (US$ Million)

Table 9 Global Automated Hematology Analyzer Market Value, By End-User, 2025, 2029 & 2033 (US$ Million)

Table 10 Global Automated Hematology Analyzer Market Value, By End-User, 2022-2033 (US$ Million)

Table 11 Global Automated Hematology Analyzer Market Value, By Region, 2025, 2029 & 2033 (US$ Million)

Table 12 Global Automated Hematology Analyzer Market Value, By Region, 2022-2033 (US$ Million)

Table 13 North America Automated Hematology Analyzer Market Value, By Product Type, 2022-2033 (US$ Million)

Table 14 North America Automated Hematology Analyzer Market Value, By Application, 2022-2033 (US$ Million)

Table 15 North America Automated Hematology Analyzer Market Value, By End-User, 2022-2033 (US$ Million)

Table 16 North America Automated Hematology Analyzer Market Value, By Country, 2022-2033 (US$ Million)

Table 17 Asia-Pacific Automated Hematology Analyzer Market Value, By Product Type, 2022-2033 (US$ Million)

Table 18 Asia-Pacific Automated Hematology Analyzer Market Value, By Application, 2022-2033 (US$ Million)

Table 19 Asia-Pacific Automated Hematology Analyzer Market Value, By End-User, 2022-2033 (US$ Million)

Table 20 Asia-Pacific Automated Hematology Analyzer Market Value, By Country, 2022-2033 (US$ Million)

Table 21 Europe Automated Hematology Analyzer Market Value, By Product Type, 2022-2033 (US$ Million)

Table 22 Europe Automated Hematology Analyzer Market Value, By Application, 2022-2033 (US$ Million)

Table 23 Europe Automated Hematology Analyzer Market Value, By End-User, 2022-2033 (US$ Million)

Table 24 Europe Automated Hematology Analyzer Market Value, By Country, 2022-2033 (US$ Million)

Table 25 South America Automated Hematology Analyzer Market Value, By Product Type, 2022-2033 (US$ Million)

Table 26 South America Automated Hematology Analyzer Market Value, By Application, 2022-2033 (US$ Million)

Table 27 South America Automated Hematology Analyzer Market Value, By End-User, 2022-2033 (US$ Million)

Table 28 South America Automated Hematology Analyzer Market Value, By Country, 2022-2033 (US$ Million)

Table 29 Middle East and Africa Automated Hematology Analyzer Market Value, By Product Type, 2022-2033 (US$ Million)

Table 30 Middle East and Africa Automated Hematology Analyzer Market Value, By Application, 2022-2033 (US$ Million)

Table 31 Middle East and Africa Automated Hematology Analyzer Market Value, By End-User, 2022-2033 (US$ Million)

Table 32 Middle East and Africa Automated Hematology Analyzer Market Value, By Country, 2022-2033 (US$ Million)

Table 33 Beckman Coulter, Inc: Overview

Table 34 Beckman Coulter, Inc: Product Portfolio

Table 35 Beckman Coulter, Inc: Key Developments

Table 36 Accurex: Overview

Table 37 Accurex: Product Portfolio

Table 38 Accurex: Key Developments

Table 39 Sysmex: Overview

Table 40 Sysmex: Product Portfolio

Table 41 Sysmex: Key Developments

Table 42 Shenzhen Mindray Bio-Medical Electronics Co., Ltd: Overview

Table 43 Shenzhen Mindray Bio-Medical Electronics Co., Ltd: Product Portfolio

Table 44 Shenzhen Mindray Bio-Medical Electronics Co., Ltd: Key Developments

Table 45 Abbott: Overview

Table 46 Abbott: Product Portfolio

Table 47 Abbott: Key Developments

Table 48 HORIBA Group: Overview

Table 49 HORIBA Group: Product Portfolio

Table 50 HORIBA Group: Key Developments

Table 51 BiobaseBiodusty(Shandong), Co., Ltd.: Overview

Table 52 BiobaseBiodusty(Shandong), Co., Ltd.: Product Portfolio

Table 53 BiobaseBiodusty(Shandong), Co., Ltd.: Key Developments

Table 54 Erba Group: Overview

Table 55 Erba Group: Product Portfolio

Table 56 Erba Group: Key Developments

Table 57 Labtron Equipment Ltd.: Overview

Table 58 Labtron Equipment Ltd.: Product Portfolio

Table 59 Labtron Equipment Ltd.: Key Developments

Table 60 Trivitron Healthcare: Overview

Table 61 Trivitron Healthcare: Product Portfolio

Table 62 Trivitron Healthcare: Key Developments

그림 목록 (Figures)

List of Figures Figure 1 Global Automated Hematology Analyzer Market Value, 2022-2033 (US$ Million)

Figure 2 Global Automated Hematology Analyzer Market Share, By Product Type, 2024 & 2033 (%)

Figure 3 Global Automated Hematology Analyzer Market Share, By Application, 2024 & 2033 (%)

Figure 4 Global Automated Hematology Analyzer Market Share, By End-User, 2024 & 2033 (%)

Figure 5 Global Automated Hematology Analyzer Market Share, By Region, 2024 & 2033 (%)

Figure 6 Global Automated Hematology Analyzer Market Y-o-Y Growth, By Product Type, 2023-2033 (%)

Figure 7 3-Part Differential Hematology Analyzers Automated Hematology Analyzer Market Value, 2022-2033 (US$ Million)

Figure 8 5-Part Differential Hematology Analyzers Automated Hematology Analyzer Market Value, 2022-2033 (US$ Million)

Figure 9 Advanced Analyzers Automated Hematology Analyzer Market Value, 2022-2033 (US$ Million)

Figure 10 Global Automated Hematology Analyzer Market Y-o-Y Growth, By Application, 2023-2033 (%)

Figure 11 Diagnostic Testing Application in Global Automated Hematology Analyzer Market Value, 2022-2033 (US$ Million)

Figure 12 Blood Screening Application in Global Automated Hematology Analyzer Market Value, 2022-2033 (US$ Million)

Figure 13 Treatment Monitoring Application in Global Automated Hematology Analyzer Market Value, 2022-2033 (US$ Million)

Figure 14 Research and Development Application in Global Automated Hematology Analyzer Market Value, 2022-2033 (US$ Million)

Figure 15 Others Application in Global Automated Hematology Analyzer Market Value, 2022-2033 (US$ Million)

Figure 16 Global Automated Hematology Analyzer Market Y-o-Y Growth, By End-User, 2023-2033 (%)

Figure 17 Hospitals End-User in Global Automated Hematology Analyzer Market Value, 2022-2033 (US$ Million)

Figure 18 Clinical Laboratories End-User in Global Automated Hematology Analyzer Market Value, 2022-2033 (US$ Million)

Figure 19 Academic and Research Institutes End-User in Global Automated Hematology Analyzer Market Value, 2022-2033 (US$ Million)

Figure 20 Others End-User in Global Automated Hematology Analyzer Market Value, 2022-2033 (US$ Million)

Figure 21 Global Automated Hematology Analyzer Market Y-o-Y Growth, By Region, 2023-2033 (%)

Figure 22 North America Automated Hematology Analyzer Market Value, 2022-2033 (US$ Million)

Figure 23 North America Automated Hematology Analyzer Market Share, By Product Type, 2024 & 2033 (%)

Figure 24 North America Automated Hematology Analyzer Market Share, By Application, 2024 & 2033 (%)

Figure 25 North America Automated Hematology Analyzer Market Share, By End-User, 2024 & 2033 (%)

Figure 26 North America Automated Hematology Analyzer Market Share, By Country, 2024 & 2033 (%)

Figure 27 Asia-Pacific Automated Hematology Analyzer Market Value, 2022-2033 (US$ Million)

Figure 28 Asia-Pacific Automated Hematology Analyzer Market Share, By Product Type, 2024 & 2033 (%)

Figure 29 Asia-Pacific Automated Hematology Analyzer Market Share, By Application, 2024 & 2033 (%)

Figure 30 Asia-Pacific Automated Hematology Analyzer Market Share, By End-User, 2024 & 2033 (%)

Figure 31 Asia-Pacific Automated Hematology Analyzer Market Share, By Country, 2024 & 2033 (%)

Figure 32 Europe Automated Hematology Analyzer Market Value, 2022-2033 (US$ Million)

Figure 33 Europe Automated Hematology Analyzer Market Share, By Product Type, 2024 & 2033 (%)

Figure 34 Europe Automated Hematology Analyzer Market Share, By Application, 2024 & 2033 (%)

Figure 35 Europe Automated Hematology Analyzer Market Share, By End-User, 2024 & 2033 (%)

Figure 36 Europe Automated Hematology Analyzer Market Share, By Country, 2024 & 2033 (%)

Figure 37 South America Automated Hematology Analyzer Market Value, 2022-2033 (US$ Million)

Figure 38 South America Automated Hematology Analyzer Market Share, By Product Type, 2024 & 2033 (%)

Figure 39 South America Automated Hematology Analyzer Market Share, By Application, 2024 & 2033 (%)

Figure 40 South America Automated Hematology Analyzer Market Share, By End-User, 2024 & 2033 (%)

Figure 41 South America Automated Hematology Analyzer Market Share, By Country, 2024 & 2033 (%)

Figure 42 Middle East and Africa Automated Hematology Analyzer Market Value, 2022-2033 (US$ Million)

Figure 43 Middle East and Africa Automated Hematology Analyzer Market Share, By Product Type, 2024 & 2033 (%)

Figure 44 Middle East and Africa Automated Hematology Analyzer Market Share, By Application, 2024 & 2033 (%)

Figure 45 Middle East and Africa Automated Hematology Analyzer Market Share, By End-User, 2024 & 2033 (%)

Figure 46 Beckman Coulter, Inc: Financials

Figure 47 Accurex: Financials

Figure 48 Sysmex: Financials

Figure 49 Shenzhen Mindray Bio-Medical Electronics Co., Ltd: Financials

Figure 50 Abbott: Financials

Figure 51 HORIBA Group: Financials

Figure 52 BiobaseBiodusty(Shandong), Co., Ltd.: Financials

Figure 53 Erba Group: Financials

Figure 54 Labtron Equipment Ltd.: Financials

Figure 55 Trivitron Healthcare: Financials

글로벌 자동 혈액 분석기 시장 – 2024-2031

Global automated hematology analyzer Market - 2024-2031